Differential effects of psychoactive drugs in adolescents and adults

Critical Reviews in Neurobiology

Volumn 17, Issue 2, 2005, Pages 51-67

  Izenwasser, Sari ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Adolescence; Amphetamine; Cannabinoid; Cocaine; Development; Nicotine

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; AMPHETAMINE; APOMORPHINE; CANNABINOID; CANNABINOID RECEPTOR AGONIST; CLONIDINE; COCAINE; DOPAMINE AUTORECEPTOR; HALOPERIDOL; METHAMPHETAMINE; NICOTINE; PSYCHOSTIMULANT AGENT; PSYCHOTROPIC AGENT; SEROTONIN TRANSPORTER;

ADOLESCENT DEVELOPMENT; ADULTHOOD; BRAIN FUNCTION; CHILD BEHAVIOR; DEVELOPMENTAL STAGE; DOSE RESPONSE; DRUG EFFECT; DRUG SELF ADMINISTRATION; DRUG SENSITIZATION; LOCOMOTION; NEUROCHEMISTRY; NEUROTOXICITY; NONHUMAN; PLACE PREFERENCE; REVIEW; SEX DIFFERENCE;

EID: 33746786810     PISSN: 08920915     EISSN: None     Source Type: Journal    
DOI: 10.1615/critrevneurobiol.v17.i2.10     Document Type: Review

References (89)

1. Fishman M, Bruner A, Adger Jr. H. Substance abuse among children and adolescents. Pediatr Rev. 1997;18:394-403.
2. Centers for Disease Control and Prevention. Tobacco use among middle and high school students - United States, 2002. MMWR Morb Mortal Weekly Report. 2003;52:1096-8.
3. The National Center on Addiction and Substance Abuse at Columbia University (CASA). National Survey of American Attitudes on Substance Abuse VIII: Teens and Parents. 2003.
4. Witt ED. Mechanisms of alcohol abuse and alcoholism in adolescents: a case for developing animal models. Behav Neural Biol. 1994;62:168-77.
5. Noisin EL, Thomas WE. Ontogeny of dopaminergic function in the rat midbrain tegmentum, corpus striatum and frontal cortex. Dev Brain Res. 1988;41:241-52.
6. Estroff TW, Schwartz RH, Hoffmann NG. Adolescent cocaine abuse. Addictive potential, behavioral and psychiatric effects. Clin Pediatr. 1989;28:550-5.
7. Weiss RD, Mirin SM, Bartel RL. Cocaine. Washington, London: American Psychiatric Press; 1994.
8. Lynskey MT, Heath AC, Bucholz KK, Slutske WS, Madden PA, Nelson EC, et al. Escalation of drug use in early-onset cannabis users vs cotwin controls. JAMA. 2003;289(4):427-33.
9. Kandel DB. Does marijuana use cause the use of other drugs? JAMA. 2003;289(4):482-3.
10. National Survey on Drug Use and Health (NSDUH). Results from the 2002 National Survey on Drug Use and Health. Substance Abuse and Mental Health Services Administration. Office of Applied Studies. Rockville, MD. 2002:1-3.
11. Wilson W, Matthew R, Turkington T, Hawk T, Coleman RE, Provenzale J. Brain morphological changes and early marijuana use: a magnetic resonance and positron emission tomography study. J Addict Dis. 2000;19(1):1-22.
12. Spear NE, Molina JC. Fetal or infantile exposure to ethanol promotes ethanol ingestion in adolescence and adulthood: a theoretical review. Alcohol Clin Exp Res. 2005;29(6):909-29.
13. Spear LP, Varlinskaya EI. Adolescence. Alcohol sensitivity, tolerance, and intake. Recent Dev Alcohol. 2005;17:143-59.
14. McBride WJ, Bell RL, Rodd ZA, Strother WN, Murphy JM. Adolescent alcohol drinking and its long-range consequences. Studies with animal models. Recent Dev Alcohol. 2005;17:123-42.
15. Spear L. Modeling adolescent development and alcohol use in animals. Alcohol Res Health. 2000;24(2):115-23.
16. Spear LP, Brake SC. Periadolescence: age-development behavior and psychopharmacological responsivity in rats. Dev Psychobio. 1983;16(2):83-109.
17. Reinstein DK, McClearn D, Isaacson RL. The development of responsiveness to dopaminergic agonists. Brain Res. 1978;150:216-23.
18. Reinstein DK, Isaacson RL. Clonidine sensitivity in the developing rat. Brain Res. 1977;135:378-82.
19. Lanier LP, Isaacson RL. Early developmental changes in the locomotor response to amphetamine and their relation to hippocampal function. Brain Res. 1977;126:567-75.
20. Laviola G, Wood RD, Kuhn C, Francis R, Spear LP. Cocaine sensitization in periadolescent and adult rats. J Pharmacol Exp Ther. 1995;275(1):345-57.
21. Shalaby IA, Spear LP. Psychopharmacological effects of low and high doses of apomorphine during ontogeny. Eur J Pharmacol. 1980;67:451-9.
22. Spear LP, Shalaby IA, Brick J. Chronic administration of haloperidol during development: behavioral and psychopharmacological effects. Psychopharmacology. 1980;70:47-58.
23. Bowman BP, Kuhn CM. Age-related differences in the chronic and acute response to cocaine in the rat. Dev Psychobio. 1996;29(7):597-611.
24. Collins SL, Izenwasser S. Cocaine differentially alters behavior and neurochemistry in periadolescent versus adult rats. Dev Brain Res. 2002;138:27-34.
25. Niculescu M, Ehrlich ME, Unterwald EM. Age-specific behavioral responses to psychostimulants in mice. Pharmacol Biochem Behav. 2005;82(2):280-8.
26. Bolanos CA, Glatt SJ, Jackson D. Subsensitivity to dopaminergic drugs in periadolescent rats: a behavioral and neurochemical analysis. Dev Brain Res. 1998;111:25-33.
27. Laviola G, Pascucci T, Pieretti S. Striatal dopamine sensitization to D-amphetamine in periadolescent but not in adult rats. Pharmacol Biochem Behav. 2001;68:115-24.
28. Kolta MG, Scalzo FM, Ali SF, Holson RR. Ontogeny of the enhanced behavioral response to amphetamine in amphetamine-pretreated rats. Psychopharmacology. 1990;100:377-82.
29. Adriani W, Laviola G. Elevated levels of impulsivity and reduced place conditioning with d-amphetamine: two behavioral features of adolescence in mice. Behav Neurosci. 2003;117(1):695-703.
30. Piper BJ, Fraiman JB, Meyer JS. Repeated MDMA ("Ecstasy") exposure in adolescent male rats alters temperature regulation, spontaneous motor activity, attention, and serotonin transporter binding. Dev Psychobio. 2005;47(2):145-57.
31. Achat-Mendes C, Ali SF, Itzhak Y. Differential effects of amphetamines-induced neurotoxicity on appetitive and aversive Pavlovian conditioning in mice. Neuropsychopharmacology. 2005;30(6):1128-37.
32. Fone KCF, Beckett SRG, Topham IA, Swettenham J, Ball M, Maddocks L. Long-term changes in social interaction and reward following repeaeted MDMA administrations to adoloscent rats without accompanying serotonergic neurotoxicity. Psychopharmacology. 2002;159:437-44.
33. Fletcher PJ, Robinson SR, Slippoy DL. Pre-exposure to (±) 2,4-methylenedioxymethamphetamine (MDMA) facilitates acquisition of intravenous cocaine self-administration in rats. Neuropsychopharmacology. 2001;25(2):195-203.
34. Broaddus WC, Bennett Jr. JP. Postnatal development of striatal dopamine function. I. An explanation of D1 and D2 receptors, adenylate cyclase regulation and presynaptic markers. Brain Res Dev Brain Res. 1990;52(1-2):275-1.
35. Tarazi FI, Tomasini EC, Baldessarini RJ. Postnatal development of dopamine D1-like receptors in rat cortical and striatolimbic brain regions: an autoradiographic study. Dev Neurosci. 1999;21(1):43-9.
36. Teicher MH, Andersen SL, Hostetter Jr. JC. Evidence for dopamine receptor pruning between adolescence and adulthood in striatum but not nucleus accumbens. Dev Brain Res. 1995;89:167-72.
37. Moll GH, Mehnert C, Wicker M, Bock N, Rothenberger A, Ruther E, et al. Age-associated changes in the densities of presynaptic monoamine transporters in different regions of the rat brain from early juvenile life to late adulthood. Dev Brain Res. 2000;119:251-7.
38. McCarthy LE, Mannelli P, Niculescu M, Gingrich K, Unterwald EM, Ehrlich ME. The distribution of cocaine in mice differs by age and strain. Neurotoxicol Teratol. 2004;26:839-48.
39. Caster JM, Walker QD, Kuhn CM. Enhanced behavioral response to repeated-dose cocaine in adolescent rats. Psychopharmacology. 2005;183:218-25.
40. Wiener HL, Reith MEA. Correlation between cocaine-induced locomotion and cocaine disposition in the brain among four inbred strains of mice. Pharmacol Biochem Behav. 1990;36:699-701.
41. Reith MEA, Benuck M, Lajtha A. Cocaine disposition in the brain after continuous or intermittent treatment and locomotor stimulation in mice. J Pharmacol Exp Ther. 1987;243(1):281-7.
42. Benuck M, Lajtha A, Reith ME. Pharmacokinetics of systemically administered cocaine and locomotor stimulation in mice. J Pharmacol Exp Ther. 1987;243(1):144-9.
43. Kokoshka JM, Fleckenstein AE, Wilkins DG, Hanson GR. Age-dependent differential responses of monoaminergic systems to high doses of methamphetamine. J Neurochem. 2000;75(5):2095-102.
44. Pu C, Vorhees CV. Developmental dissociation of methamphetamine-induced depletion of dopaminergic terminals and astrocyte reaction in rat striatum. Brain Res Dev Brain Res. 1993;72(2):325-8.
45. Cappon GD, Morford LL, Vorhees CV. Ontogeny of methamphetamine-induced neurotoxicity and associated hyperthermic response. Brain Res Dev Brain Res. 1997;103(2):155-62.
46. Andersen SL, LeBlanc CJ, Lyss PJ. Maturational increases in c-fos expression in the ascending dopamine systems. Synapse. 2001;41(4):345-50.
47. Ehrlich ME, Sommer J, Canas E, Unterwald EM. Periadolescent mice show enhanced DFosB upregulation in response to cocaine and amphetamine. J Neurosci. 2002;22(21):9155-9.
48. Wallace TL, Gudelsky GA, Vorhees CV. Alterations in diurnal and nocturnal locomotor activity in rats treated with a monoamine-depleting regimen of methamphetamine or 3,4-methylenedioxymethamphetamine. Psychopharmacology. 2001;153:321-6.
49. Broening HW, Bacon L, W. Slikker J. Age modulates the long-term but not the acute effects of the serotonergic neurotoxicant 3,4- methylenedioxymethamphetamine. J Pharmacol Exp Ther. 1994;271(1):285-93.
50. Aguirre N, Barrionuevo M, Lasheras B, Rio JD. The role of dopaminergic systems in the perinatal sensitivity to 3,4-methylenedioxymethamphetamine- induced neurotoxicity in rats. J Pharmacol Exp Ther. 1998;286(3):1159-65.
51. Cannon DM, Keenan AK, Guiry PJ, Buon C, Baird AW, McBean GJ. In vitro neuronal and vascular responses to 5-HT in rats chronically exposed to MDMA. Brit J Pharmacol. 2001;134:1455-60.
52. Adriani W, Spijker S, Deroche-Gammonet V, Laviola G, Le Moal M, Smit AB, et al. Evidence for enhanced neurobehavioral vulnerability to nicotine during periadolescence in rats. J Neurosci. 2003;23(11):4712-6.
53. Collins SL, Izenwasser S. Chronic nicotine differentially alters cocaine-induced locomotor activity in adolescent vs. adult male and female rats. Neuropharmacology. 2004;46:349-62.
54. Collins SL, Montano R, Izenwasser S. Nicotine treatment produces persistent increases in amphetamine-stimulated locomotor activity in periadolescent male but not female or adult male rats. Dev Brain Res. 2004;153:175-87.
55. Cruz FC, Delucia R, Planeta CS. Differential behavioral and neuroendocrine effects of repeated nicotine in adolescent and adult rats. Pharmacol Biochem Behav. 2005;80(3):411-7.
56. Schochet TL, Kelley AE, Landry CF. Differential behavioral effects of nicotine exposure in adolescent and adult rats. Psychopharmacology. 2004;175:265-73.
57. Faraday MM, Elliott BM, Phillips JM, Grunberg NE. Adolescent and adult male rats differ in sensitivity to nicotine's activity effects. Pharmacol Biochem Behav. 2003;74(4):917-31.
58. Trauth JA, Seidler FJ, Slotkin TA. Persistent and delayed behavioral changes after nicotine treatment in adolescent rats. Brain Res. 2000;880:167-72.
59. Levin ED, Rezvani AH, Montoya D, Rose JE, Swartzwelder HS. Adolescent-onset nicotine self-administration modeled in female rats. Psychopharmacology. 2003;169:141-9.
60. Vastola BJ, Douglas LA, Varlinskaya EI, Spear LP. Nicotine-induced conditioned place preference in adolescent and adult rats. Physiol Behav. 2002;77:107-14.
61. Belluzzi JD, Lee AG, Oliff HS, Leslie FM. Age-dependent effects of nicotine on locomotor activity and conditioned place preference in rats. Psychopharmacology. 2004;174:389-95.
62. Cheeta S, Irvine EE, Tucci S, Sandhu J, File SE. In adolescence, female rats are more sensitive to the anxiolytic effect of nicotine than are male rats. Neuropsychopharmacology. 2001;25(4):601-7.
63. Slawecki CJ, Gilder A, Roth J, Ehlers CL. Increased anxiety-like behavior in adult rats exposed to nicotine as adolescents. Pharmacol Biochem Behav. 2003;75:355-61.
64. Elliott BM, Faraday MM, Phillips JM, Grunberg NE. Effects of nicotine on elevated plus maze and locomotor activity in male and female adolescent and adult rats. Pharmacol Biochem Behav. 2004;77(1):21-8.
65. McMillen BA, Davis BJ, Williams HL, Soderstrom K. Periadolescent nicotine exposure causes heterologous sensitization to cocaine reinforcement. Eur J Pharmacol. 2005;509(2-3):161-4.
66. Klein LC. Effects of adolescent nicotine exposure on opioid consumption and neuroendocrine responses in adult male and female rats. Exp Clin Psychopharmacol. 2001;9:251-61.
67. Kelley BM, Middaugh LD. Periadolescent nicotine exposure reduces cocaine reward in adult mice. J Addict Dis. 1999;18(3):27-39.
68. Kelley BM, Rowan JD. Long-term, low-level adolescent nicotine exposure produces dose-dependent changes in cocaine sensitivity and reward in mice. Int J Dev Neurosci. 2004;22:339-48.
69. Trauth JA, Seidler FJ, McCook EC, Slotkin TA. Adolescent nicotine exposure causes persistent upregulation of nicotinic cholinergic receptors in rat brain regions. Brain Res. 1999;851:9-19.
70. Abreu-Villaca Y, Seidler FJ, Qiao D, Tate CA, Cousins MM, Thillai I, et al. Short-term adolescent nicotine exposure has immediate and persistent effects on cholinergic systems: critical periods, patterns of exposure, dose thresholds. Neuropsychopharmacology. 2003;28:1935-49.
71. Abreu-Villaca Y, Seidler FJ, Tate CA, Cousins MM, Slotkin TA. Prenatal nicotine exposure alters the response to nicotine administration in adolescence: effects on cholinergic systems during exposure and withdrawal. Neuropsychopharmacology. 2004;29(5):879-90.
72. Trauth JA, McCook EC, Seidler FJ, Slotkin TA. Modeling adolescent nicotine exposure: effects on cholinergic systems in rat brain regions. Brain Res. 2000;873:18-25.
73. Trauth JA, Seidler FJ, Ali SF, Slotkin TA. Adolescent nicotine exposure produces immediate and long-term changes in CNS noradrenergic and dopaminergic function. Brain Res. 2001;892:269-80.
74. Badanich KA, Kirstein CL. Nicotine administration significantly alters accumbal dopamine in the adult but not in the adolescent rat. Ann NY Acad Sci. 2004;1021:410-7.
75. Schochet TL, Kelley AE, Landry CF. Differential expression of arc mRNA and other plasticity-related genes induced by nicotine in adolescent rat forebrain. Neuroscience. 2005;135(1):285-97.
76. Xu Z, Seidler FJ, Ali SF, Slikker WJ, Slotkin TA. Fetal and adolescent nicotine administration: effects on CNS serotonergic systems. Brain Res. 2001;914:166-78.
77. Chow FA, Seidler FJ, McCook EC, Slotkin TA. Adolescent nicotine exposure alters cardiac autonomic responsiveness: b-adrenergic and m2-muscarinic receptors and their linkage to adenylyl cyclase. Brain Res. 2000;878:119-26.
78. Xu Z, Seidler FJ, Cousins MM, Slikker WJ, Slotkin TA. Adolescent nicotine administration alters serotonin receptors and cell signaling mediated through adenylyl cyclase. Brain Res. 2002;951:280-92.
79. Gonzalez S, Cascio MG, Fernandez-Ruiz J, Fezza F, Marzo VD, Ramos JA. Changes in endocannabinoid contents in the brain of rats chronically exposed to nicotine, ethanol or cocaine. Brain Res. 2002;954:73-81.
80. Arnold J, Topple A, Hunt G, McGregor I. Effects of pre-exposure and co-administration of the cannabinoid receptor agonist CP 55,940 on behavioral sensitization to cocaine. Eur J Pharmacol. 1998;354:9-16.
81. Higuera A, Biscaia M, Fernández B, Miguéns M, Olmo Nd, Torres I, et al. Pre-exposure to cannabinoid agonist CP 55,940 during rat early adolescence facilitates acquisition of cocaine self-administration behavior in the adulthood [abstract]. College on Problems of Drug Dependence. 2005.
82. Biscaia M, Fernandez B, Marco EM, Rubio M, Guaza C, Ambrosio E, et al. Chronic treatment with CP55, 940 during the periadolescent period differentially affects the behavioural responses of male and female rats in the adulthood. Psychopharmacology. 2003;170:301-8.
83. Breivogel CS, Scates SM, Beletskaya IO, Lowery OB, Aceto MD, Martin BR. The effects of D9 -tetrahydrocannabinol physical dependence on brain cannabinoid receptors. Eur J Pharmacol. 2003;459:139-50.
84. de Fonseca FR, Gorriti MA, Fernandez-Ruiz JJ, Palomo T, Ramos JA. Downregulation of rat brain cannabinoid binding sites after chronic delta 9-tetrahydrocannabinol treatment. Pharmacol Biochem Behav. 1994;47(1):33-40.
85. Romero J, Berrendero F, Manzanares J, Perez A, Corchero J, Fuentes JA, et al. Time-course of the cannabinoid receptor down-regulation in the adult rat brain caused by repeated exposure to D9-tetrahydrocannabinol. Synapse. 1998;30(3):298-308.
86. Romero J, Garcia-Palomero E, Castro JG, Garcia-Gil L, Ramos JA, Fernandez-Ruiz JJ. Effects of chronic exposure to D9-tetrahydrocannabinol on cannabinoid receptor binding and mRNA levels in several rat brain regions. Mol Brain Res. 1997;46(1-2):100-8.
87. Pistis M, Perra S, Pillolla G, Melis M, Muntoni AL, Gessa GL. Adolescent exposure to cannabinoids induces long-lasting changes in the response to drugs of abuse of rat midbrain dopamine neurons. Biol Psychiat. 2004;56(2):86-94.
88. Faraday MM, Elliott BM, Grunberg NE. Adult vs. adolescent rats differ in biobehavioral responses to chronic nicotine administration. Pharmacol Biochem Behav. 2001;70:475-89.
89. Wallace TL, Gudelsky GA, Vorhees CV. Neurotoxic regimen of methamphetamine producers evidence of behavioral sensitization in the rat. Synapse. 2001;39:1-7.